Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
about
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Disease burden and conditionin ...... ildren's Oncology Group study.
@en
Disease burden and conditionin ...... ildren's Oncology Group study.
@nl
type
label
Disease burden and conditionin ...... ildren's Oncology Group study.
@en
Disease burden and conditionin ...... ildren's Oncology Group study.
@nl
prefLabel
Disease burden and conditionin ...... ildren's Oncology Group study.
@en
Disease burden and conditionin ...... ildren's Oncology Group study.
@nl
P2093
P2860
P50
P356
P1476
Disease burden and conditionin ...... hildren's Oncology Group study
@en
P2093
Adam B Olshen
Betsy Hirsch
Donna Wall
Joel S Parker
Micah Skeens
Mignon L Loh
Neil Patel
Parinda A Mehta
Prakash Satwani
P2860
P304
P356
10.1002/PBC.27034
P577
2018-03-12T00:00:00Z